rs773527127

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PP3_Moderate

The NM_032193.4(RNASEH2C):​c.115G>T​(p.Asp39Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000493 in 1,419,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D39N) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000049 ( 0 hom. )

Consequence

RNASEH2C
NM_032193.4 missense

Scores

5
7
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.257

Publications

3 publications found
Variant links:
Genes affected
RNASEH2C (HGNC:24116): (ribonuclease H2 subunit C) This gene encodes a ribonuclease H subunit that can cleave ribonucleotides from RNA:DNA duplexes. Mutations in this gene cause Aicardi-Goutieres syndrome-3, a disease that causes severe neurologic dysfunction. A pseudogene for this gene has been identified on chromosome Y, near the sex determining region Y (SRY) gene. [provided by RefSeq, Jul 2008]
RNASEH2C Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM1
In a chain Ribonuclease H2 subunit C (size 163) in uniprot entity RNH2C_HUMAN there are 7 pathogenic changes around while only 2 benign (78%) in NM_032193.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.899

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNASEH2CNM_032193.4 linkc.115G>T p.Asp39Tyr missense_variant Exon 1 of 4 ENST00000308418.10 NP_115569.2 Q8TDP1A0A024R5B3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNASEH2CENST00000308418.10 linkc.115G>T p.Asp39Tyr missense_variant Exon 1 of 4 1 NM_032193.4 ENSP00000308193.5 Q8TDP1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
182918
AF XY:
0.00000995
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000257
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000493
AC:
7
AN:
1419906
Hom.:
0
Cov.:
32
AF XY:
0.00000568
AC XY:
4
AN XY:
703640
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32290
American (AMR)
AF:
0.00
AC:
0
AN:
40376
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37046
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44244
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4922
European-Non Finnish (NFE)
AF:
0.00000639
AC:
7
AN:
1095018
Other (OTH)
AF:
0.00
AC:
0
AN:
58766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000516
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000167
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 18, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RNASEH2C c.115G>T (p.Asp39Tyr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 182918 control chromosomes. c.115G>T has been reported in the literature in two compound heterozygous individuals affected with Aicardi Goutieres Syndrome (Ramantani_2010, Garau_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31130681, 20131292). ClinVar contains an entry for this variant (Variation ID: 464266). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Aicardi-Goutieres syndrome 3 Uncertain:1
Jul 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 39 of the RNASEH2C protein (p.Asp39Tyr). This variant is present in population databases (rs773527127, gnomAD 0.003%). This missense change has been observed in individuals with Aicardi–Goutières syndrome (PMID: 20131292, 31130681). ClinVar contains an entry for this variant (Variation ID: 464266). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Uncertain
0.10
CADD
Benign
17
DANN
Benign
0.68
DEOGEN2
Pathogenic
0.86
D;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.77
.;T
M_CAP
Pathogenic
0.70
D
MetaRNN
Pathogenic
0.90
D;D
MetaSVM
Uncertain
0.10
D
MutationAssessor
Uncertain
2.4
M;.
PhyloP100
0.26
PrimateAI
Uncertain
0.50
T
PROVEAN
Pathogenic
-5.5
D;D
REVEL
Uncertain
0.53
Sift
Uncertain
0.0070
D;D
Sift4G
Uncertain
0.011
D;D
Polyphen
0.97
D;.
Vest4
0.24
MutPred
0.89
Gain of phosphorylation at D39 (P = 0.0499);Gain of phosphorylation at D39 (P = 0.0499);
MVP
0.84
MPC
1.1
ClinPred
0.95
D
GERP RS
2.0
PromoterAI
0.026
Neutral
Varity_R
0.20
gMVP
0.72
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773527127; hg19: chr11-65488115; API